Abstract:Background. Microarray technology enables a standardized, objective assessment of oncological diagnosis and prognosis. However, such studies are typically specific to certain cancer types, and the results have limited use due to inadequate validation in large patient cohorts. Discovery of genes commonly regulated in cancer may have an important implication in understanding the common molecular mechanism of cancer. Methods and Findings. We described an integrated gene-expression analysis of 2,186 samples from 39 studies to identify and validate a cancer type-independent gene signature that can identify cancer patients for a wide variety of human malignancies. The commonness of gene expression in 20 types of common cancer was assessed in 20 training datasets. The discriminative power of a signature defined by these common cancer genes was evaluated in the other 19 independent datasets including novel cancer types. QRT-PCR and tissue microarray were used to validate commonly regulated genes in multiple cancer types. We identified 187 genes dysregulated in nearly all cancerous tissue samples. The 187-gene signature can robustly predict cancer versus normal status for a wide variety of human malignancies with an overall accuracy of 92.6%. We further refined our signature to 28 genes confirmed by QRT-PCR. The refined signature still achieved 80% accuracy of classifying samples from mixed cancer types. This signature performs well in the prediction of novel cancer types that were not represented in training datasets. We also identified three biological pathways including glycolysis, cell cycle checkpoint II and plk3 pathways in which most genes are systematically up-regulated in many types of cancer. Conclusions. The identified signature has captured essential transcriptional features of neoplastic transformation and progression in general. These findings will help to elucidate the common molecular mechanism of cancer, and provide new insights into cancer diagnostics, prognostics and therapy.

Identification of Cancer Trait Genes and Association Analysis under Pan-Cancer

Combining Genome-Wide Studies of Breast, Prostate, Ovarian and Endometrial Cancers Maps Cross-Cancer Susceptibility Loci and Identifies New Genetic Associations

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.

Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis

Multi-cancer molecular signatures and their interrelationships

Comprehensive Analysis of Differential Gene Expression to Identify Common Gene Signatures in Multiple Cancers

Identification, Modeling and Simulation of Key Pathways Underlying Certain Cancers

Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis

A pan-cancer analysis of prognostic genes.

Functional and Embedding Feature Analysis for Pan-Cancer Classification

Identification of Cancer Development Related Pathways Based on Co-Expression Analyses

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data

Identifying Cancer Specific Signaling Pathways Based on the Dysregulation Between Genes

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups

A Common Gene Expression Signature Analysis Method for Multiple Types of Cancer

Identifying Candidate Cancer Genes Based on Their Somatic Mutations Co-Occurring with Cancer Genes in Cancer Genome Profiling

Identifying driver pathways based on a parameter-free model and a partheno-genetic algorithm

Eqtl Analysis from Co-Localization of 2739 GWAS Loci Detects Associated Genes Across 14 Human Cancers.

Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers